A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol

Toxicology and Applied Pharmacology

Volumn 152, Issue 2, 1998, Pages 339-359

  Fisher, Jeffrey W ^a   Mahle, Deirdre ^a   Abbas, Richat ^a  

^a AIR FORCE RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAL HYDRATE; CYTOCHROME P450; DICHLOROACETIC ACID; DRUG METABOLITE; TRICHLOROACETIC ACID; TRICHLOROETHANOL; TRICHLOROETHANOL GLUCURONIDE; TRICHLOROETHYLENE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREATH ANALYSIS; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG OXIDATION; DRUG UPTAKE; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SEX DIFFERENCE; URINARY EXCRETION; VAPOR;

EID: 0032192157     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8486     Document Type: Article

References (51)

1. Abbas R., Fisher J. W. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol. Appl. Pharmacol. 127:1997;15-30.
2. American Conference of Governmental Industrial Hygienists, 1994, Threshold Limit Values for Chemicals Substances and Physical Agents and Biological Exposure Indices, American Conference of Governmental Industrial Hygienists, Cincinnati, OH.
3. Allen B. C., Fisher J. W. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Analysis. 13:1993;71-86.
4. Agency for Toxic Substances and Disease Registry, 1996, Toxicological Profile for Trichloroethylene, U.S. Department of Health and Human Services, Atlanta.
5. Brashear W. T., Bishop C. T., Abbas R. Electrospray analysis of biological samples for trace amounts of trichloroacetic acid, dichloroacetic acid and monochloroacetic acid. J. Anal. Toxicol. 21:1997;330-334.
6. Bruning T., Vamvakas S., Makropoulos V., Birner G. Acute intoxication with trichloroethylene: Clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage. Toxicol. Sci. 41:1998;157-165.
7. Bull R. J., Sanchez I. M., Nelson M. A., Larson J. L., Lansing A. L. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology. 63:1990;341-359.
8. Cole W. J., Mitchell R. G., Salamonsen R. F. Isolation, characterization and quantitation of chloral hydrate as a transient metabolite of trichloroethylene in man using electron capture gas chromatography and mass fragmentography. J. Pharm. Pharmacol. 27:1975;167-171.
9. Cowles A. L., Borgstedt H. H., Gillies A. J. Tissue weights and rates of blood flow in man for the prediction of anesthetic uptake and distribution. Anesthesiology. 35:1971;523-526.
10. Cronin W. J. IV, Oswald E. J., Shelley M. L., Fisher J. W., Flemming C. D. A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling. Risk Analysis. 15:1995;555-565.
11. Dalbey W., Bingham E. Metabolism of trichloroethylene by the isolated perfused lung. Toxicol. Appl. Pharmacol. 43:1978;267-277.
12. Daniel F. D., DeAngelo A. B., Stober J. A., Olson G. R., Page N. P. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Toxicol. Appl. Pharmacol. 19:1992;159-168.
13. Davidson I. W. F., Beliles R. P. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab. Rev. 23:1991;493-599.
14. Ertle T., Henschler D., Müller G., Spassowski M. Metabolism of trichloroethylene in man I. The significance of trichloroethanol in long-term exposure conditions. Arch. Toxicol. 29:1972;171-188.
15. Fernandez J. G., Droz P. O., Humbert B. E., Caperos J. R. Trichloroethylene exposure: Simulation of uptake, excretion, and metabolism using a mathematical model. Br. J. Ind. Med. 34:1977;43-55.
16. Gargas M. L., Burgess R. J., Voisard D. E., Cason G. H., Andersen M. E. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98:1989;87-99.
17. Greenberg M. S., Abbas R. A., Fisher J. W. A physiologically based pharmacokinetic model for inhaled trichloroethylene and its major metabolites in B6C3F1 mice. Toxicologist. 36:1997;163.
18. Hake, C. L. Stewart, R. D. Peterson, J. E. Dodd, H. C. 1973, Urinary metabolites from controlled exposures of humans to trichloroethylene, National Institute for Occupational Safety and Health, Cincinnati, OH.
19. Hathway D. E. Consideration of the evidence for mechanisms of 1,1,2-trichloroethylene metabolism, including new identification of its dichloroacetic acid and trichloroacetic acid metabolites in mice. Can. Lett. 8:1980;263-269.
20. Henderson G. N., Yan Z., James M. O., Davydova N., Stacpoole P. W. Kinetics and metabolism of chloral hydrate in children: Identification of dichloroacetate as a metabolite. Biochem. Biophys. Res. Commun. 235:1997;695-698.
21. Hinrichsen H., Halabi A., Fuhrman G., Kirch W. Dose-dependent heart rate reducing effect of nizatidine, a histamine H2-receptor antagonist. Br. J. Clin. Pharmacol. 35:1993;461-466.
22. Hobara T., Kobayashi H., Kawamoto T., Iwamoto S., Hirota S., Shimazu W., Sakai T. Extrahepatic organs metabolism of inhaled trichloroethylene. Toxicology. 41:1986;289-303.
23. International Commission on Radiological Protection, 1975, Report of the Task Group on Reference Man.
24. Jepson G. W., Hoover D. K., Black R. K., McCafferty J. D., Mahle D. A., Gearhart J. M. A partition coefficient determination method for nonvolatile chemicals in biological tissues. Fundam. Appl. Toxicol. 22:1994;519-524.
25. Ketcha M. M., Stevenson D. K., Warren D. A., Bishop C. T., Brashear W. T. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J. Anal. Toxicol. 20:1996;236-241.
26. Kimmerle G., Eben A. Metabolism, excretion and toxicology of trichloroethylene after inhalation. Arch. Toxicol. 30:1973;127-138.
27. Koizumi A. Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rats and man. Br. J. Ind. Med. 46:1989;239-249.
28. Larson J. L., Bull R. J. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol. Appl. Pharmacol. 115:1992;268-277.
29. Lash L. H., Xu Y., Elfarra A. A., Duescher R. J., Parker J. C. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab. Dispos. 23:1995;846-853.
30. Layton D. W. Metabolically consistent breathing rates for use in dose assessments. Health Phys. 64:1993;23-36.
31. Lipscomb J. C., Garrett C. M., Snawder J. E. Cytochrome P450-dependent metabolism of trichloroethylene: Interindividual differences in humans. Toxicol. Appl. Pharmacol. 142:1997;311-318.
32. Maltoni C., Lefemine G., Cotti G. Experimental research of trichloroethylene carcinogenesis. Archives of Research on Industrial Carcinogenesis. 1986;Princeton Scientific, Princeton. p. 1-393.
33. Marshall E. K., Owens A. H. Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol. Bull. Johns Hopkins Hosp. 95:1955;1-18.
34. Moghaddam A. P., Abbas R., Fisher J. W., Lipscomb J. C. The role of mouse intestinal microflora in the metabolism of trichloroethylene, anin vivo. Hum. Exp. Toxicol. 16:1997;629-635.
35. Moghaddam A. P., Abbas R., Fisher J. W., Stavrou S., Lipscomb J. C. Formation of dichloroacetic acid by rat and mouse gut microflora, anin vitro. Biochem. Biophys. Res. Commun. 228:1996;639-645.
36. Monster A. C., Boersma G., Duba W. C. Pharmacokinetics of trichloroethylene in volunteers, influence of workload and exposure concentration. Int. Arch. Occup. Environ. Health. 38:1976;87-102.
37. Müller G., Spassovaki M., Henschler D. Trichloroethylene exposure and trichloroethylene metabolites in urine and blood. Arch. Toxicol. 29:1972;335-340.
38. Müller G., Spassowski M., Henschler D. Metabolism of trichloroethylene in man. II. Pharmacokinetic of metabolites. Arch. Toxicol. 32:1974;283-295.
39. Müller G., Spassowski M., Henschler D. Metabolism of trichloroethylene in man. III. Interaction of trichloroethylene and ethanol. Arch. Toxicol. 33:1975;173-189.
40. National Cancer Institute, 1976, Carcinogenesis bioassay for trichloroethylene, National Cancer Institute.
41. Nomiyama K., Nomiyama H. Metabolism of trichloroethylene in human: Sex differences in urinary excretion of trichloroacetic acid and trichloroethanol. Int. Arch. Arbeitsmed. 28:1971;37-48.
42. Paykoc Z. V., Powell J. F. The excretion of sodium trichloroacetate. J. Pharmacol. Exp. Ther. 85:1945;289-293.
43. Pleil J. D., Lindstrom A. B. Collection of a single alveolar exhaled breath for volatile organic compounds analysis. Am. J. Ind. Med. 28:1995;109-121.
44. Raymer J. H., Kizakevich P. N., McCartney M. L., Pellezzari E. D. Facilities for human exposure studies. Environ. Sci. Technol. 27:1993;1733-1735.
45. Sato A., Nakajima T., Fujiwara Y., Murayama N. A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. Br. J. Ind. Med. 34:1977;56-63.
46. Sellers E. M., Koch-Weser J. Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs. Ann. NY Acad. Sci. 179:1971;213-225.
47. Stenner R. D., Merdink J. L., Fisher J. W., Bull R. J. Physiologically based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites. Risk Analysis. 1998.
48. Stewart R. D., Dodd H. C., Gray H. H., Erley D. S. Experimental human exposure to trichloethylene. Arch. Environ. Health. 20:1970;64-71.
49. Templin M. V., Parker J. C., Bull R. J. Relative formation of dichloroacetate and tichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol. Appl. Pharmacol. 123:1993;1-8.
50. Triebig G., Essing H. G., Schaller K. H., Valentin H. Biochemical and psychological examinations of trichloroethylene exposed volunteers. Zentralbl. Bakteriol. Abt. 1 Orig. B. Hyg. 163:1976;383-416.
51. U.S. EPA, 1995, Drinking Water Regulations and Health Advisories, Office of Water, US Environmental Protection Agency, Washington, D.C.